Current Neuro-Oncology
Volume
26 Number 22
10 October 2024
Home > Publications > Current Neuro-Oncology > Volume 26, Year 2024 > Number 22, 10 October
Chainey J, Kim MJ, Chan VK, Au K.
Patient
experiences in high-grade gliomas: from symptoms to radiotherapy.
BMJ
Support Palliat Care. 2024 Oct 1:spcare-2023-004659.
doi:
10.1136/spcare-2023-004659. PMID:
39353720. Observational study˰
ˍ
Zeyen T, Böhm L, Paech D, Schäfer N, Tzaridis T, Duffy
C, Nitsch L, Schneider M, Potthoff AL, Schneider-Rothhaar JL,
Steinbach JP, Hau P, Kowalski T, Seidel C, Krex D, Grauer O,
Goldbrunner R, Zeiner PS, Tabatabai G, Galldiks N, Stummer W,
Hattingen E, Glas M, Gkika E, Vatter H, Radbruch A, Herrlinger U,
Weller J, Schaub C.
Quantitative
assessment of residual tumor is a strong and independent predictor
of survival in methylated glioblastoma following radiochemotherapy
with CCNU/TMZ.
Neuro
Oncol. 2024 Oct 1:noae205. doi:
10.1093/neuonc/noae205. PMID:
39351820. Observational study˰
ˍ
Cai T, Jin T, Guan Y, Zou W, Wang X, Zhu Y.
Hyperbaric
oxygen therapy enhances restoration of physical functional in
patients with recurrent glioma: A case report.
Oncol
Lett. 2024 Oct 2;28(6):583. doi:
10.3892/ol.2024.14716. PMID:
39421317. Case report. ˍ
Haisraely O, Taliansky A, Sivan M, Lawerence Y.
Re-irradiation
of anaplastic meningioma: higher dose and concomitant Bevacizumab
may improve progression-free survival.
Radiat
Oncol. 2024 Oct 2;19(1):135. doi:
10.1186/s13014-024-02486-7. PMID:
39358739. Observational study.
ˍ
Kacimi SEO, Dehais C, Feuvret L, Chinot O, Carpentier C,
Bronnimann C, Vauleon E, Djelad A, Cohen-Jonathan Moyal E,
Langlois O, Campone M, Ducloie M, Noel G, Cuzzubbo S, Taillandier
L, Ramirez C, Younan N, Menei P, Dhermain F, Desenclos C,
Ghiringhelli F, Bourg V, Ricard D, Faillot T, Appay R, Tabouret E,
Nichelli L, Mathon B, Thomas A, Tran S, Bielle F, Alentorn A,
Iorgulescu JB, Boëlle PY, Labreche K, Hoang-Xuan K, Sanson M,
Idbaih A, Figarella-Branger D, Ducray F, Touat M; POLA Network.
Survival Outcomes Associated With
First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in
Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade
3 Oligodendroglioma.
J
Clin Oncol. 2024 Oct 2:JCO2400049. doi:
10.1200/JCO.24.00049. PMID:
39356975. Observational study˰
ˍ
Ghimire P, Kamaludin A, Palau BF, Lavrador JP, Gullan R, Vergani
F, Bhangoo R, Ashkan K.
MGMT
methylation and its prognostic significance in inoperable
IDH-wildtype glioblastoma: the MGMT-GBM study.
Acta
Neurochir (Wien). 2024 Oct 5;166(1):394. doi:
10.1007/s00701-024-06300-x. PMID:
39367282. Observational study.
ˍ
Huang Y, Shan Y, Zhang W, Printzis C, Pesce L, Maeser D, Stanhope
C, Stranger BE, Huang RS.
Sex
differences in the molecular profile of adult diffuse glioma are
shaped by IDH status and tumor microenvironment.
Neuro
Oncol. 2024 Oct 5:noae207. doi:
10.1093/neuonc/noae207. PMID:
39367624. Observational study˰
ˍ
Li Z, Lin Z, Liu H, Xiao R, Lin C, Zhu W, Luo J, Xu S, Chi F, He
H.
Treatment Continuity and Bone
Marrow Suppression in Whole-Brain and Whole-Spinal Cord
Radiotherapy for Medulloblastoma Patients.
Clin
Med Insights Oncol. 2024 Oct 5;18:11795549241286431.
doi:
10.1177/11795549241286431. PMID:
39371257. Observational study.
ˍ
Huangfu L, Zha B, Li P, Wang L, Liu X, Cui H, Li Y, Wu J, Shi S,
Yang Y, Sun X, Gao S, Li H, Yang D, Zheng Y.
A
phase I clinical trial of sonodynamic therapy combined with
radiotherapy for brainstem gliomas.
Int
J Cancer. 2024 Oct 8. doi:
10.1002/ijc.35218. PMID:
39377640. Interventional study˰
ˍ
*Price M, Ballard C, Benedetti J, Neff C, Cioffi G, Waite KA,
Kruchko C, Barnholtz-Sloan JS, Ostrom QT.
CBTRUS
Statistical Report: Primary Brain and Other Central Nervous System
Tumors Diagnosed in the United States in 2017-2021.
Neuro
Oncol. 2024 Oct 6;26(Supplement_6):vi1-vi85. doi:
10.1093/neuonc/noae145. PMID:
39371035. Observational study. ˍ
*Schwalbe EC, Lindsey JC, Danilenko M, Hill RM, Crosier S, Ryan
SL, Williamson D, Castle J, Hicks D, Kool M, Milde T, Korshunov A,
Pfister SM, Bailey S, Clifford SC.
Molecular
and clinical heterogeneity within MYC-family amplified
medulloblastoma is associated with survival outcomes: A
multicenter cohort study.
Neuro
Oncol. 2024 Oct 8:noae178. doi:
10.1093/neuonc/noae178. PMID:
39377358. Observational study. ˍ
Shen H, Mei Q, Chai X, Jiang Y, Liu A, Liu J.
The
prognostic significance of synchronous metastasis in glioblastoma
multiforme patients: a propensity score-matched analysis using
SEER data.
Front
Neurol. 2024 Oct 8;15:1429826. doi:
10.3389/fneur.2024.1429826. PMID:
39440248. Observational study. ˍ
Gao L, Li Y, Zhu H, Liu Y, Li S, Li L, Zhang J, Shen N, Zhu W.
Application of preoperative advanced
diffusion magnetic resonance imaging in evaluating the
postoperative recurrence of lower grade gliomas.
Cancer
Imaging. 2024 Oct 9;24(1):134. doi:
10.1186/s40644-024-00782-9. PMID:
39385297. Observational study. ˍ
Luckett T, DiGiacomo M, Heneka N, Disalvo D, Garcia M, Schaeffer
I, Attwood R, Phillips J.
A
qualitative study of specialist multidisciplinary clinician
perspectives on barriers/facilitators to care for children with
brain cancer and their families: "We're
a little bit different to our adult counterparts".
Palliat
Support Care. 2024 Oct 9:1-6. doi:
10.1017/S1478951524001421. PMID:
39379286. Observational study. ˍ
*Rincon-Torroella J, Rakovec M, Kalluri AL, Jiang K, Weber-Levine
C, Parker M, Raj D, Materi J, Sepehri S, Ferres A, Schreck KC,
Aldecoa I, Lucas CG, Sair HI, Redmond KJ, Holdhoff M, Weingart J,
Brem H, Sánchez JJG, Ye X, Bettegowda C.
Impact
of upfront adjuvant chemoradiation on survival in patients with
molecularly defined oligodendroglioma: the benefits of PCV over
TMZ.
J
Neurooncol. 2024 Oct 9. doi:
10.1007/s11060-024-04829-6. PMID:
39382617. Observational study˰
ˍ
Sun MN, Li SQ, Guo Y, Zhou JF, Fu DD, Hua XY, Yu XJ, Lai MY, Cai
LB, Shi CZ.
Clinicopathological,
immunohistochemical and therapeutic approaches on survival in
patients with epithelioid glioblastoma: Institutional experience
in the management of 58 patients.
Neurosurg
Rev. 2024 Oct 9;47(1):763. doi:
10.1007/s10143-024-02957-1. PMID:
39382734. Observational study. ˍ
Griessmair M, Schramm S, Ziegenfeuter J, Canisius J, Jung K,
Delbridge C, Schmidt-Graf F, Mitsdoerffer M, Zimmer C, Meyer B,
Metz MC, Wiestler B.
Advanced imaging
reveals enhanced malignancy in glioblastomas involving the
subventricular zone: evidence of increased infiltrative growth and
perfusion.
J
Neurooncol. 2024 Oct 10. doi:
10.1007/s11060-024-04849-2. PMID:
39387957. Observational study. ˍ
Lucas Calduch A, Macià Garau M, Villà Freixa S,
García Expósito N, Modolell Farré I, Majós
Torró C, Pons Escoda A, Mesía Barroso C, Vilariño
Quintela N, Rosselló Gómez A, Plans Ahicart G,
Martínez García M, Esteve Gómez A, Bruna
Escuer J.
Salvage reirradiation for
recurrent glioblastoma: a retrospective case series analysis.
Clin
Transl Oncol. 2024 Oct 10. doi:
10.1007/s12094-024-03750-8. PMID:
39388047. Observational study˰
ˍ
Valerio JE, Wolf AL, Mantilla-Farfan P, Aguirre Vera GJ,
Fernández-Gómez MP, Alvarez-Pinzon AM.
Efficacy
and Cognitive Outcomes of Gamma Knife Radiosurgery in Glioblastoma
Management for Elderly Patients.
J
Pers Med. 2024 Oct 10;14(10):1049. doi:
10.3390/jpm14101049. PMID:
39452556. Observational study. ˍ